Clinical Trials
45 trialsNivolumab and Ipilimumab in Treating Patients With Rare Tumors
National Cancer Institute (NCI)
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Parabilis Medicines, Inc.
A Study of Nirogacestat in Japanese Adults With Desmoid Tumors/Aggressive Fibromatosis (DT/AF)
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Nirogacestat in Premenopausal Females With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Children's Oncology Group
A Study in Adults With Desmoid Tumors
Elpiscience Biopharma, Ltd.
PRISM
Dana-Farber Cancer Institute
A Study of a New Drug, Nirogacestat, for Treating Desmoid Tumors That Cannot be Removed by Surgery
Children's Oncology Group
ALTITUDES
Centre Oscar Lambret
PALANGI3
Centre Oscar Lambret
A Study of E7386 in Participants With Advanced Solid Tumor Including Colorectal Cancer (CRC)
Eisai Inc.
RINGSIDE
Immunome, Inc.
SarcAblate
Oxford University Hospitals NHS Trust
CRYODESMO01
University Hospital, Strasbourg, France
Endoxifen in Adults With Hormone Receptor Positive Solid Tumors
National Institutes of Health Clinical Center (CC)
CRYODESMO-02
University Hospital, Strasbourg, France
Study of Cryoablation and Nirogacestat for Desmoid Tumor
Stanford University
Cryotherapy in the Treatment of Desmoid Tumors
Istituto Ortopedico Rizzoli
RCT of Two Noncrosslinked Porcine Acellular Dermal Matrices in Ab Wall Reconstruction
Ohio State University
Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers
Sarcoma Oncology Research Center, LLC
DeFi
SpringWorks Therapeutics, Inc.
MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid Tumors
Children's National Research Institute
A Study to Evaluate the Safety and Efficacy of Vactosertib and Imatinib in Patients With Advanced Desmoid Tumor
Yonsei University
RFAdesmoid
Blokhin's Russian Cancer Research Center
Phase II Trial of the Gamma-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors/Aggressive Fibromatosis
National Institutes of Health Clinical Center (CC)
Clinical Study of Anlotinib Combined With Chemotherapy in the Treatment of Unresectable Advanced Desmoid Tumor
Henan Cancer Hospital
A Pilot Study Evaluating the Use of mTor Inhibitor Sirolimus in Children and Young Adults With Desmoid-Type Fibromatosis
MaineHealth
Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis
National Cancer Institute (NCI)
Phase I, Open-label, Non-randomized Study to Evaluate Safety of BC2059
Iterion Therapeutics
A Randomized, Double-blind,Phase â…¢ Study of Liposome Doxorubicin in Desmoid Tumor
Sun Yat-sen University
ABRADES
Grupo Espanol de Investigacion en Sarcomas
Doxorubicin Eluting Intra-arterial Embolization for Aggressive Desmoid Fibromatosis
Rabin Medical Center
Sulindac and Tamoxifen in Treating Patients With Desmoid Tumor
Children's Oncology Group
18F-FES PET/CT in Imaging Patients With Desmoid Tumors
Vanderbilt-Ingram Cancer Center
HIFU Hyperthermia With Liposomal Doxorubicin (DOXIL) for Relapsed or Refractory Pediatric and Young Adult Solid Tumors
University of Texas Southwestern Medical Center
Study to Evaluate Imatinib in Desmoid Tumors
Heidelberg University
Effect of Hydroxyurea as Treatment for Primary Desmoid Tumors
Children's Hospital of Philadelphia
Imatinib Mesylate in Treating Patients With Recurrent or Refractory Fibromatosis
UNICANCER
Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas
Memorial Sloan Kettering Cancer Center
Toremifene in Desmoid Tumor: Prospective Clinical Trial and Identification of Potential Molecular Targets
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Vinblastine and Methotrexate in Treating Children With Desmoid Tumors
Children's Oncology Group
Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain
INSYS Therapeutics Inc
Radiation Therapy in Treating Patients With Aggressive Fibromatoses
European Organisation for Research and Treatment of Cancer - EORTC
Toremifene in Treating Patients With Desmoid Tumors
National Cancer Institute (NCI)
MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma
National Institutes of Health Clinical Center (CC)